Anti-vista antibodies and fragments
US10273301B2 · kind B2 · utility
4Cited by
1References
44Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 22, 2014 |
| Grant date | Apr 30, 2019 |
| Priority date | — |
| Expiry date | Nov 30, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel antibodies and fragments that bind to a V-domain Ig Suppressor of T cell Activation (VISTA), and methods of making and using same. Methods of use include methods of treatment of cancer, including leukemias, lymphomas, solid tumors and melanomas.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.